Riboxin (inosine) ampoules 20 mg/ml, 10 ml, # 10

Riboxin Active Substance:

inosine;

1 ml of solution contains 20 mg inosine;

Excipients:

hexamethylenetetramine, water for injection.

Dosage Form:

Solution for injection.

Clear, colorless liquid.

Riboxin is Produced in:

Capsules, tablets, and injectable solution.

Pharmacological Properties:

Inosine (Riboxin) is a metabolic agent, a stimulant of biochemical processes, a precursor of ATP. It increases energy balance, improves coronary circulation and metabolic processes in the myocardium. It has an antihypoxic effect. It is used for ischemic heart disease (myocardial infarction, angina pectoris), cardiomyopathy, heart rhythm disturbances, myocarditis, myocardial dystrophy, liver diseases (hepatitis, liver cirrhosis, fatty liver), gastric ulcer, and duodenal ulcer, open-angle glaucoma.

Riboxin Effects:

• Inosine is a purine derivative, a precursor of adenosine triphosphate (ATP), and is a vital source of energy in bodybuilding.
• Inosine stimulates the synthesis of nucleotides, enhancing the activity of certain enzymes of the Krebs cycle.
• As a nucleoside, inosine can penetrate cells and increase the energy balance of the myocardium.
• It improves coronary circulation and metabolic processes in the myocardium. It has an antihypoxic effect.

Recommendations for Use in Sports:

• Prevention of metabolic damage (CMD) of the myocardium during extreme physical exertion.
• Myocardial dystrophy on the background of heavy physical exertion.
• Heart rhythm disorders.
• Stress cardiomyopathies.
• Medicinal damage to the liver.
• Liver diseases, acute and chronic hepatitis.
• Peptic ulcer of the stomach and duodenum.

Method of Administration and Dosage:

When using the parenteral form of the drug when administered intravenously, the patient receives 2% Riboxin solution diluted with 250 ml of 9% sodium chloride solution or 5% glucose solution.

The drug is injected intravenously by drop or slow jet. On the first day, the patient receives 0.2 g once; in the future, the dose of Riboxin can be increased to 0.4 g from 1 to 2 times a day. The duration of the course of treatment can vary from 10 to 15 days.

Contraindications:

Inosine hypersensitivity, gout, severe renal failure.

Side Effects:

Inosine is generally well tolerated; in some cases, bradycardia, itching, flushing of the skin are possible; in cases of an allergic reaction, the drug is canceled. In rare cases, there is an increase in the concentration of uric acid in the blood. With prolonged use in large doses, exacerbation of gout is possible.

Storage Conditions and Periods:

Riboxin is stored in a cool, dry, and dark place. The shelf life of the medicinal product is 2 years. It is strictly forbidden to use the drug after the expiration date.